Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Marvell Technology Inc ha un obiettivo di prezzo consensuale di $100.35, basato sulle valutazioni degli ultimi 31 analisti. Il massimo è $150 emesso da Barclays il gennaio 17, 2025, mentre il minimo è $67 emesso da Redburn Atlantic il maggio 28, 2025. Le ultime 3 valutazioni degli analisti sono state pubblicate da Morgan Stanley, Goldman Sachs e Cantor Fitzgerald il luglio 30, 2025, luglio 10, 2025 e giugno 18, 2025. Con un obiettivo di prezzo medio di $76.67 tra Morgan Stanley, Goldman Sachs e Cantor Fitzgerald, c'è un cambiamento implicito del 4.12% upside per Marvell Technology Inc secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/30/2025 | 8.65% | Morgan Stanley | $73 → $80 | Maintains | Equal-Weight | |||
07/10/2025 | 1.86% | Goldman Sachs | → $75 | Initiates | → Neutral | |||
06/18/2025 | 1.86% | Cantor Fitzgerald | $60 → $75 | Maintains | Neutral | |||
06/18/2025 | 56.19% | B. Riley Securities | $110 → $115 | Maintains | Buy | |||
06/18/2025 | 3.22% | Melius Research | $67 → $76 | Maintains | Hold | |||
06/18/2025 | 22.23% | B of A Securities | $80 → $90 | Maintains | Buy | |||
06/18/2025 | 29.02% | Benchmark | $95 → $95 | Reiterates | Buy → Buy | |||
06/18/2025 | 15.44% | Needham | $85 → $85 | Reiterates | Buy → Buy | |||
06/18/2025 | 68.41% | Rosenblatt | $124 → $124 | Maintains | Buy | |||
06/05/2025 | 49.4% | China Renaissance | — | → $110 | Initiates | → Buy | ||
05/30/2025 | -2.21% | B of A Securities | $72 → $72 | Maintains | Buy | |||
05/30/2025 | -0.86% | Morgan Stanley | $70 → $73 | Maintains | Equal-Weight | |||
05/30/2025 | 22.23% | Loop Capital | $110 → $90 | Maintains | Buy | |||
05/30/2025 | 15.44% | Deutsche Bank | $100 → $85 | Maintains | Buy | |||
05/30/2025 | 22.23% | Raymond James | $110 → $90 | Reiterates | Outperform → Outperform | |||
05/30/2025 | 80.63% | Evercore ISI Group | $135 → $133 | Maintains | Outperform | |||
05/30/2025 | 15.44% | Piper Sandler | $95 → $85 | Reiterates | Overweight → Overweight | |||
05/30/2025 | 22.23% | Keybanc | $115 → $90 | Maintains | Overweight | |||
05/30/2025 | 29.02% | Wells Fargo | $120 → $95 | Maintains | Overweight | |||
05/30/2025 | -18.51% | Cantor Fitzgerald | $60 → $60 | Reiterates | Neutral → Neutral | |||
05/30/2025 | 68.41% | Rosenblatt | $124 → $124 | Maintains | Buy | |||
05/30/2025 | 29.02% | Benchmark | $95 → $95 | Reiterates | Buy → Buy | |||
05/30/2025 | 15.44% | Needham | $100 → $85 | Maintains | Buy | |||
05/28/2025 | -9% | Melius Research | $66 → $67 | Maintains | Neutral | |||
05/28/2025 | -9% | Redburn Atlantic | → $67 | Initiates | → Neutral | |||
05/27/2025 | -4.93% | Morgan Stanley | $90 → $70 | Maintains | Equal-Weight | |||
05/27/2025 | 22.23% | Susquehanna | $110 → $90 | Maintains | Positive | |||
05/22/2025 | -10.36% | Melius Research | $66 → $66 | Downgrade | Buy → Hold | |||
05/19/2025 | 35.81% | UBS | $110 → $100 | Maintains | Buy | |||
05/07/2025 | 29.02% | Benchmark | $135 → $95 | Maintains | Buy | |||
05/07/2025 | -18.51% | Cantor Fitzgerald | $125 → $60 | Downgrade | Overweight → Neutral | |||
04/22/2025 | 8.65% | Barclays | $130 → $80 | Maintains | Overweight | |||
04/17/2025 | 8.65% | Stifel | $115 → $80 | Maintains | Buy | |||
04/16/2025 | -2.21% | B of A Securities | $120 → $72 | Maintains | Buy | |||
04/11/2025 | 30.38% | Citigroup | $122 → $96 | Maintains | Buy | |||
03/06/2025 | 49.4% | UBS | $125 → $110 | Maintains | Buy | |||
03/06/2025 | 62.98% | Wells Fargo | $140 → $120 | Maintains | Overweight | |||
03/06/2025 | 49.4% | Raymond James | $130 → $110 | Maintains | Outperform | |||
03/06/2025 | 22.23% | Morgan Stanley | $113 → $90 | Maintains | Equal-Weight | |||
03/06/2025 | 56.19% | Stifel | $130 → $115 | Maintains | Buy | |||
03/06/2025 | 65.69% | Citigroup | $136 → $122 | Maintains | Buy | |||
03/06/2025 | 49.4% | Loop Capital | → $110 | Upgrade | Hold → Buy | |||
03/06/2025 | 29.02% | Piper Sandler | $120 → $95 | Maintains | Overweight | |||
03/06/2025 | 76.56% | Barclays | $150 → $130 | Maintains | Overweight | |||
03/06/2025 | 56.19% | Keybanc | $135 → $115 | Maintains | Overweight | |||
03/06/2025 | 62.98% | B of A Securities | $150 → $120 | Maintains | Buy | |||
03/06/2025 | 83.35% | Benchmark | $135 → $135 | Reiterates | Buy → Buy | |||
03/06/2025 | 90.14% | Rosenblatt | $140 → $140 | Maintains | Buy | |||
03/06/2025 | 35.81% | Needham | $120 → $100 | Maintains | Buy | |||
02/24/2025 | 69.77% | UBS | $115 → $125 | Maintains | Buy | |||
01/28/2025 | 53.47% | Morgan Stanley | $120 → $113 | Maintains | Equal-Weight | |||
01/22/2025 | 83.35% | Keybanc | $125 → $135 | Maintains | Overweight | |||
01/17/2025 | 103.72% | Barclays | $115 → $150 | Maintains | Overweight | |||
01/13/2025 | 90.14% | Susquehanna | $125 → $140 | Maintains | Positive | |||
01/13/2025 | 90.14% | Wells Fargo | $130 → $140 | Maintains | Overweight | |||
01/10/2025 | 77.92% | Goldman Sachs | $115 → $131 | Maintains | Buy | |||
01/06/2025 | 102.36% | Craig-Hallum | $132 → $149 | Maintains | Buy | |||
01/06/2025 | 76.56% | Stifel | $125 → $130 | Maintains | Buy | |||
12/20/2024 | 62.98% | Morgan Stanley | $102 → $120 | Maintains | Equal-Weight | |||
12/05/2024 | 56.19% | Goldman Sachs | $87 → $115 | Maintains | Buy | |||
12/04/2024 | 76.56% | JP Morgan | $90 → $130 | Maintains | Overweight | |||
12/04/2024 | 49.4% | Loop Capital | $95 → $110 | Maintains | Hold | |||
12/04/2024 | 52.11% | Citigroup | $91 → $112 | Maintains | Buy | |||
12/04/2024 | 83.35% | Cantor Fitzgerald | $120 → $135 | Reiterates | Overweight → Overweight | |||
12/04/2024 | 69.77% | Keybanc | $95 → $125 | Maintains | Overweight | |||
12/04/2024 | 56.19% | UBS | $110 → $115 | Maintains | Buy | |||
12/04/2024 | 79.27% | Craig-Hallum | $88 → $132 | Maintains | Buy | |||
12/04/2024 | 69.77% | Oppenheimer | $110 → $125 | Reiterates | Outperform → Outperform | |||
12/04/2024 | 62.98% | Piper Sandler | $100 → $120 | Reiterates | Overweight → Overweight | |||
12/04/2024 | 69.77% | Susquehanna | $110 → $125 | Maintains | Positive | |||
12/04/2024 | 69.77% | Stifel | $114 → $125 | Reiterates | Buy → Buy | |||
12/04/2024 | 38.53% | Morgan Stanley | $82 → $102 | Maintains | Equal-Weight | |||
12/04/2024 | 72.48% | Evercore ISI Group | $122 → $127 | Maintains | Outperform | |||
12/04/2024 | 69.77% | B of A Securities | $108 → $125 | Maintains | Buy | |||
12/04/2024 | 90.14% | Rosenblatt | $120 → $140 | Maintains | Buy | |||
12/04/2024 | 83.35% | Benchmark | $115 → $135 | Reiterates | Buy → Buy | |||
12/04/2024 | 62.98% | Needham | $95 → $120 | Maintains | Buy | |||
12/04/2024 | 56.19% | Barclays | $85 → $115 | Maintains | Overweight | |||
12/02/2024 | 65.69% | Evercore ISI Group | $98 → $122 | Maintains | Outperform | |||
11/27/2024 | 49.4% | Susquehanna | $95 → $110 | Maintains | Positive | |||
11/26/2024 | 49.4% | Oppenheimer | $90 → $110 | Maintains | Outperform | |||
11/26/2024 | 49.4% | Wells Fargo | $90 → $110 | Maintains | Overweight | |||
11/11/2024 | 29.02% | Loop Capital | → $95 | Initiates | → Hold | |||
10/14/2024 | 23.59% | Citigroup | $91 → $91 | Maintains | Buy | |||
08/30/2024 | 62.98% | Rosenblatt | $100 → $120 | Maintains | Buy | |||
08/30/2024 | 22.23% | B of A Securities | $85 → $90 | Maintains | Buy | |||
08/30/2024 | 56.19% | Benchmark | $105 → $115 | Maintains | Buy | |||
08/30/2024 | 15.44% | Cantor Fitzgerald | $85 → $85 | Reiterates | Overweight → Overweight | |||
08/30/2024 | 15.44% | Barclays | $80 → $85 | Maintains | Overweight | |||
08/30/2024 | 35.81% | Piper Sandler | $100 → $100 | Reiterates | Overweight → Overweight | |||
08/30/2024 | 18.16% | Goldman Sachs | $77 → $87 | Maintains | Buy | |||
08/30/2024 | 29.02% | Stifel | $90 → $95 | Reiterates | Buy → Buy | |||
08/30/2024 | 33.1% | Evercore ISI Group | $91 → $98 | Maintains | Outperform | |||
08/30/2024 | 29.02% | Roth MKM | $95 → $95 | Maintains | Buy | |||
08/30/2024 | 11.37% | Morgan Stanley | $77 → $82 | Maintains | Equal-Weight | |||
08/30/2024 | 29.02% | Needham | $95 → $95 | Reiterates | Buy → Buy | |||
08/22/2024 | 35.81% | Rosenblatt | $100 → $100 | Maintains | Buy | |||
07/09/2024 | 29.02% | Keybanc | $90 → $95 | Maintains | Overweight | |||
05/31/2024 | 8.65% | Barclays | $75 → $80 | Maintains | Overweight | |||
05/31/2024 | 22.23% | Oppenheimer | $80 → $90 | Reiterates | Outperform → Outperform |
L'ultimo obiettivo di prezzo per Marvell Tech (NASDAQ:MRVL) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $80.00 prevedendo che MRVL raggiunga rise entro 12 mesi (un possibile 8.65% upside).
L'ultima valutazione degli analisti per Marvell Tech (NASDAQ:MRVL) è stato fornita da Morgan Stanley e Marvell Tech mantenuto il suo rating equal-weight.
L'ultima revisione al rialzo di Marvell Technology Inc è avvenuta il marzo 6, 2025, quando Loop Capital ha alzato il suo obiettivo di prezzo a $110. In precedenza Loop Capital aveva a hold per Marvell Technology Inc.
L'ultima revisione al ribasso di Marvell Technology Inc si è verificata il maggio 22, 2025, quando Melius Research ha modificato il suo obiettivo di prezzo da $66 a $66 per Marvell Technology Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Marvell Tech e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Marvell Tech è stata depositata il luglio 30, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a luglio 30, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Marvell Tech (MRVL) è stata una mantenuto con un obiettivo di prezzo di $73.00 a $80.00. Il prezzo attuale a cui Marvell Tech (MRVL) è scambiato è $73.63, che è within del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.